Biometric Analysis of Melanoma Cells Due to Various Metastasis Origin
- Authors: Palkina N.V.1, Komina A.V.1, Aksenenko M.B.1, Ruksha T.G.1
-
Affiliations:
- Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
- Issue: Vol 93, No 6 (2017)
- Pages: 60-66
- Section: ORIGINAL STUDIES
- URL: https://medbiosci.ru/0042-4609/article/view/116896
- DOI: https://doi.org/10.25208/0042-4609-2017-93-6-60-66
- ID: 116896
Cite item
Full Text
Abstract
Objective: biometric analysis of melanoma cells derived from different types of primary or secondary tumors could be necessary for better understanding tumor heterogeneity as that phenomenon would affect significantly the anti-cancer therapy efficacy. Materials and Methods. A comparative analysis of melanoma cells that reflect different stages of tumor progression was accomplished with following parameters tested: intensity of apoptosis, proliferation/metabolic activity, the ratio of the cell cycle phases distribution, chromosomal constitution analysis, invasion, and migration capacity. Results. It was found that melanoma cells derived from visceral metastases characterized by a high proliferative/metabolic potential, migratory ability, and mitotic potential. Melanoma cells which represent earlier stages of carcinogenesis have higher invasive activity and percentage of polyploidy cells, indicating high mutational potential. Both cell lines have no differences in the expression of apoptosis. Conclusion. Melanoma cells derived from metastasis demonstrate various abilities for growth, migration, and invasion depending on metastasis origin. In that context, isolation of pathological cells and tissues, both native and fixed, followed by their individual testing for each patient will have a high demand for both fundamental and clinical medicine for more adequate therapy choice.
About the authors
N. V. Palkina
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
Author for correspondence.
Email: MosmanNV@yandex.ru
PhD (Medicine), Research Assistant, Department of Pathophysiology named after Prof. V. V. Ivanov
Russian FederationA. V. Komina
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
PhD (biology), Researcher, Department of Pathophysiology named after Prof. V. V. Ivanov
Russian FederationM. B. Aksenenko
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
PhD (Medicine), Associate Professor, Department of Pathophysiology named after Prof. V. V. Ivanov
Russian FederationT. G. Ruksha
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
D.Sci. (Medicine), Head of the Department of Pathophysiology named after Prof. V. V. Ivanov
Russian FederationReferences
- Каприн А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). М.: МНИОИ им. П. А. Герцена, 2017. [Kaprin A. D., Starinskiy V. V., Petrova G. V. Malignancies in Russia in 2015 (Morbidity and Mortality). M.: MNIOI im. P. A. Gertsena, 2017.]
- Ferris L. K., Harris R. J. New Diagnostic Aides for Melanoma. Dermatol. Clin. 2012;30(3):535–545.
- Ferrara G., De Vanna A. C. Fluorescence in situ Hybridization for Melanoma Diagnosis: A Review and a Reappraisal. Am. J. Dermatopathol. 2016;38(4):253–269.
- Sun X., Yu Q. Intra-Tumor Heterogeneity of Cancer Cells and its Implications for Cancer Treatment. Acta Pharmacol. Sin. 2015;36(10):1219– 1227.
- Tellez-Gabriel M., Ory B., Lamoureux F. et al. Tumour Heterogeneity: the Key Advantages of Single-Cell Analysis. Int. J. Mol. Sci. 2016;17(12):2142.
- Oettgen H. F., Aoki T., Old L. J. et al. Suspension Culture of a Pigment-Producing Cell Line Derived from a Human Malignant Melanoma. J. Natl. Cancer Inst. 1968;41(4):827–843.
- Mohr P., Eggermont A. M. M., Hauschild A. et al. Staging of Cutaneous Melanoma. Ann. Oncol. 2009;20(6):vi14–vi21.
- Lockshin A., Giovanella B. C., De Ipolyi P. D. et al. Exceptional Lethality for Nude Mice of Cells Derived from a Primary Human Melanoma. Cancer Res. 1985;45(1):345–350.
- Turajlic S., Furney S. J., Lambros M. B. et al. Whole Genome Sequencing of Matched Primary and Metastatic Acral Melanomas. Genome Res. 2012;22(2):196–207.
- Vogelstein B., Papadopoulos N., Velculescu V. E. et al. Cancer Genome Landscapes. Science. 2013;339(6127):1546–1558.
- Guan X. Cancer Metastases: Challenges and Opportunities. Acta Pharm. Sin. B. 2015;5(5):402–418.
- Zhou F., Wang W., Shen C. et al. Epigenome-Wide Association Analysis Identified Nine Skin DNA Methylation Loci for Psoriasis. J. Invest. Dermatol. 2016;136(4):779–787.
- Bin L., Leung D. Y. M. Genetic and Epigenetic Studies of Atopic Dermatitis. Allergy Asthma Clin. Immunol. 2016;12:52.
- Chew E. G. Y., Ho B. S. Y., Ramasamy S. et al. Comparative Transcriptome Profiling Provides New Insights into Mechanisms of Androgenetic Alopecia Progression. Br. J. Dermatol. 2016;176(1):265–269.
- Heywood W. E., Benatti M., Sebire N. J. et al. An Optimised Method for the Proteomic Profiling of Full Thickness Human Skin. Biol. Proced. Online. 2016;18:15.
Supplementary files
